Ventyx Biosciences Inc (VTYX)

06:10 AM

What analysts say about Ventyx Biosciences Inc. stockExceptional profit velocity - PrintWeekIndia

06:10 AM

02:35 AM

Ventyx Biosciences Inc. Stock Analysis and ForecastRapid market gains - PrintWeekIndia

02:35 AM

01:52 AM

How Ventyx Biosciences Inc. stock performs during market volatilityPredictable Return Stock Picks - Newser

01:52 AM

Jul 24, 2025

Is Ventyx Biosciences Inc. a good long term investmentUnrivaled growth potential - Autocar Professional

Jul 24, 2025

Jul 22, 2025

What drives Ventyx Biosciences Inc. stock priceTremendous growth opportunities - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Why Ventyx Biosciences Inc. stock attracts strong analyst attentionSmart Return Focused Trading - Newser

Jul 22, 2025

Jul 21, 2025

Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth? - Yahoo Finance

Jul 21, 2025

Jul 16, 2025

What makes Ventyx Biosciences Inc. stock price move sharplyFree Insider Trading Tips - Newser

Jul 16, 2025

Jul 12, 2025

Wealth Enhancement Advisory Services LLC Invests $28,000 in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Jul 12, 2025

Jul 10, 2025

Ventyx Biosciences (VTYX) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance

Jul 10, 2025

Jul 10, 2025

Analyzing the Impact of Earnings Reports on Ventyx Biosciences Inc Inc. (VTYX) Price Performance - investchronicle.com

Jul 10, 2025

Jul 03, 2025

Class Action Filed Against Ventyx Biosciences, Inc. (VTYX)April 30, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Jul 03, 2025

Jul 03, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Ventyx Biosciences, Inc. (VTYX) Shareholders - ACCESS Newswire

Jul 03, 2025

Jun 30, 2025

Ventyx Biosciences, Inc.(NasdaqGS: VTYX) dropped from Russell 3000E Index - MarketScreener

Jun 30, 2025

Jun 30, 2025

Ventyx Biosciences, Inc.(NasdaqGS: VTYX) dropped from Russell 3000 Value Index - MarketScreener

Jun 30, 2025

Jun 27, 2025

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Sold by Rhumbline Advisers - Defense World

Jun 27, 2025

Jun 23, 2025

Canaccord maintains buy rating on Ventyx stock after positive trial results - Investing.com

Jun 23, 2025

Jun 18, 2025

Ventyx stock steady as Parkinson’s drug shows biomarker reductions By Investing.com - Investing.com India

Jun 18, 2025

Jun 18, 2025

Ventyx reports positive outcomes from trial of VTX3232 for Parkinson’s - Yahoo Finance

Jun 18, 2025

Jun 18, 2025

Ventyx Therapeutics' VTX3232: A Neuroinflammation Breakthrough with Orphan Drug Pricing Power - AInvest

Jun 18, 2025

Jun 17, 2025

Ventyx Biosciences Inc’s Mixed Bag: Down -9.22% in 6 Months, Down 58.21% in 30 Days - investchronicle.com

Jun 17, 2025

Jun 17, 2025

Ventyx Biosciences Holds Steady Despite Encouraging Early Parkinson’s Trial Results - MSN

Jun 17, 2025

Jun 17, 2025

Ventyx Biosciences Announces Positive Top-Line Data from - GlobeNewswire

Jun 17, 2025

Jun 17, 2025

Ventyx Biosciences Shares Fall After Tier 2 Exploratory Biomarkers Remain Stable in Parkinson's Study - MarketScreener

Jun 17, 2025

Jun 17, 2025

Ventyx reports positive Phase 2a results for Parkinson’s drug - Investing.com

Jun 17, 2025

Jun 17, 2025

Ventyx Biosciences Insiders Placed Bullish Bets Worth US$1.26m - Yahoo.co

Jun 17, 2025

Jun 17, 2025

Ventyx Biosciences' Study of VTX3232 Met Safety, Tolerability Objectives - MarketWatch

Jun 17, 2025

Jun 17, 2025

Ventyx posts mid-stage trial win for Parkinson’s drug (VTYX) - Seeking Alpha

Jun 17, 2025

Jun 17, 2025

Ventyx Biosciences stock trades flat despite positive parkinson’s drug trial data - Investing.com Canada

Jun 17, 2025